Skip to main content

Table 1 Disease and drug groups of the discontinued medication (n = 558)

From: Mapping the methodological diversity of published drug discontinuation studies—a scoping review of study topics, objectives, and designs

 

n

Col %

Psychiatric disorder

122

21.9

Condition after transplantation

67

12.0

Epilepsy

66

11.8

Cardiovascular disease

58

10.4

Cancer disease

35

6.3

HIV or hepatitis

32

5.7

Endocrine diseases diabetes, rheumatism, lung disease, neurological disease, dementia, gastrointestinal diseases, diabetes, fungal disease, pain disorder

 

Each

1–5%

Mental retardation, post menopause, autoimmune disease, kidney disease, osteoporosis, eye disease, prostate disease, coagulation disease, collagenosis, dermatological disease, chromosome aberration

 

Each

 < 1%

Discontinued drug groups (n = 560)

 Antipsychotics

165

29.5

 Immunosuppressants

82

14.6

 Hormone therapy

57

10.2

 Antiepileptic drugs

49

8.8

 Corticoid therapy

47

8.4

 Antiviral drugs, antihypertensive drugs, diuretics, antibiotics, Parkinson’s disease medications, antifungal medication, cytostatic drugs, antidiabetic drugs, anticoagulants, bisphosphonate therapy, cardiovascular medications

 

Each 1–5%

 Opioids, antacid therapy, bronchospasmolytics, antidementia drugs, statins, antiprotozoics, analgesics, antihistamines, biliary therapeutics

 

Each

 < 1%